Metabolic benefits of 1,3-diacylglycerol in type 2 diabetes mellitus and its association with gut microbiota-derived SCFAs-GPR41-GLP-1 signaling
Food Funct., 2026, Accepted ManuscriptDOI: 10.1039/D5FO03164H, Paper Jiaomei Li, Hao Wang, Jiekai Yang, Yicheng Wang, Guo Jia, Jiaojiao Gu1,3-Diacylglycerol (1,3-DAG) is a dietary lipid with known lipid-lowering effects, yet its role in type 2 diabetes mellitus (T2DM) and gut microbiota regulation remains unclear. This study investigated the effects…The content of this RSS Feed (c) The […]
GLP-1 drugs have ‘little or no effect’ on risk of obesity-related cancers, study suggests
Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related cancers, new research suggests.
How the rise of GLP-1 drugs is shifting consumer habits
The rise in the use of GLP-1 weight-loss drugs across the U.S. is shifting not only scales, but also how Americans are spending their time and money. Washington Post retail reporter Jaclyn Peiser explains. CBS News 24/7 is the premier anchored streaming news service from CBS News and Stations that is available free to everyone […]
Structure Therapeutics Inc. (GPCR) Discusses Topline Results from ACCESS Program of Oral Small Molecule GLP-1 Receptor Agonist Transcript
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk, research shows
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.
The miracle that fades: New study reveals troubling reality of post-treatment weight regain
(NaturalNews) A large-scale study of over 1.2 million patients found that more than half (58%) of those who stop GLP-1 weight-loss drugs like Wegovy and Ozempic…
Weight-loss drug customers were caught up in telehealth scam. Here’s how to avoid being a victim
Federal Trade Commission crackdown on company selling GLP-1 is a reminder of the dangers consumers face when purchasing trending treatments online
Rising Malnutrition Risks Spark Push for Plant-Based Diets Among Ozempic Users
GLP-1 weight loss medications like Ozempic, Mounjaro, and Wegovy are rapidly growing in popularity. In fact, research from KFF last year found that about one in eight Americans had either used or were currently using a GLP-1 weight loss drug. The surge in popularity has been especially noticeable in Hollywood, where stars such as Meghan […]
7 tips for enjoying the holidays while taking a GLP-1
Sometimes it seems like the winter holidays are all about food—Grandma’s famous pie at Thanksgiving, cocoa and cookies with the neighbors, a full spread at the office potluck.
Castlight and Noom Join Forces to Tackle the GLP-1 Cost Crisis Through Integrated Digital Health
What You Should Know: – Castlight Health and Noom have formed a strategic partnership to embed Noom’s preventive health and weight management programs directly into Castlight’s health navigation platform. – The integration allows employers to purchase Noom through Castlight, granting employees seamless access to psychology-based care and GLP-1 medication management. The move is designed to […]